George Eliades
Chief Executive Officer bij Mythic Therapeutics, Inc.
Profiel
George Eliades is currently the President & Chief Executive Officer at Mythic Therapeutics, Inc. He is also a Director at the Pulmonary Fibrosis Foundation.
Previously, he served as an Independent Director at Oyster Point Pharma, Inc. from 2021 to 2023.
Prior to that, he was a Partner at Bain & Co., Inc. from 2007 to 2020.
He also held positions at Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Plc as Chief Transformation Officer & SVP-Development and Chief Transformation Officer, respectively.
Dr. Eliades received his graduate and doctorate degrees from Harvard University and his undergraduate degree from Harvard College.
Actieve functies van George Eliades
| Bedrijven | Functie | Begin |
|---|---|---|
| Pulmonary Fibrosis Foundation | Director/Board Member | - |
Mythic Therapeutics, Inc.
 Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Chief Executive Officer | 28-03-2024 |
Eerdere bekende functies van George Eliades
| Bedrijven | Functie | Einde |
|---|---|---|
| OYSR POIN | Director/Board Member | 03-01-2023 |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01-12-2020 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | - |
Opleiding van George Eliades
| Harvard University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Commercial Services |
| Pulmonary Fibrosis Foundation | |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Health Technology |
